Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
Using a combination of computation and physical observation in the laboratory, the researchers have unraveled a sophisticated process that some commonly occurring bacteria use to save themselves from the rifamycin class of antibiotics, which occur naturally and are also manufactured to treat infectious diseases.
Rifamycins work by binding to RNA polymerase, a protein essential for bacterial life.
The resistant bacteria, which occur widely in the environment and in some human pathogens, have developed a protein that can eject the antibiotic from RNA polymerase. Once the rifamycin is dislodged, they use specially adapted proteins to attack and destroy it.
The researchers identify a helicase-like protein, HelR, in Streptomyces venezuelae that confers broad-spectrum rifamycin resistance. They show that HelR also promotes tolerance to rifamycins, enabling bacterial evasion of the toxic properties of these antibiotics. HelR forms a complex with RNAP and rescues transcription inhibition by displacing rifamycins from RNAP, thereby providing resistance by target protection .
“What we’ve discovered is a brand-new trick up the sleeves of bacteria to evade this class of antibiotics,” explains the researcher. “It’s like a one-two punch. It’s fascinating and it’s so crafty.”
The discovery shows that the mechanisms of antimicrobial resistance (AMR) are more complex and highly evolved than scientists had previously recognized.
HelRs are broadly distributed in Actinobacteria, including several opportunistic Mycobacterial pathogens, offering yet another challenge for developing new rifamycin antibiotics.
Now the researchers are combing their database of tens of thousands of samples to see if other bacteria use parallel processes and whether they reveal vulnerabilities that can be exploited to create urgently needed new antibiotics.
Their work is described in a paper published in the influential journal Molecular Cell.
The author says the discovery gives him with new respect for nature’s adaptability and renews his enthusiasm for finding and exposing other methods bacteria use to ensure their survival.
“We’ve been facing this AMR problem for many years,” the author says. “Every time we think we’ve figured out all the ways bacteria resist antibiotics, along comes something like this, to let us know there are tricks we hadn’t even thought of before.”
AMR is a huge and growing global health concern that should be commanding much more attention and far more research resources, the author says.
Though the effectiveness of penicillin, rifamycin and other established antibiotic treatments is waning quickly, most pharmaceutical companies are not actively developing new antibiotics, the author says and explains that drug discovery and development is tremendously expensive, and the financial return on investment in antibiotics would be low since they don’t generate as much revenue as prescription medications that patients use for years at a time.
https://www.cell.com/molecular-cell/fulltext/S1097-2765(22)00602-5
Sophisticated mechanism that bacteria use to resist antibiotics
- 1,178 views
- Added
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Another gene that causes MND with defective mitochondria and lipid…
Read more
Insects harbor over a thousand genes from microbes, which help them…
Read more
New dementia risk genes identified!
Read more
Glycoprotein GPNMB is a possible biomarker for Parkinson's Disease…
Read more
How a gene variant protects against Alzheimer's disease
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar